Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China.

This study provides a analysis of the potential beneficial effects on health outcomes in the Chinese population after introducing PD-1 inhibitor class treatment. The findings suggest the PD-1 inhibitor class will significantly improve patient survival.